Type
Basic
- Biswas S, Anadon CM, Conejo-Garcia JR (2024). Antibodies target intracellular oncodrivers through PIGR-mediated transcytosis. Genes & Immunity. 25(1):85-86.PMID: 38092884.
- Dandia HY, Pillai MM, Sharma D, Suvarna M, Dalal N, Madhok A, Ingle A, Chiplunkar SV, Galande S, Tayalia P (2024). Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy. Military Medical Research.PMID: 38173045
- Dubey S, Mishra N, Shelke R, Varma AK (2024). Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. FEBS Journal. 291(7):1422-1438. PMID: 38129745.
- Ketkar M, Desai S, Rana P, Thorat R, Epari S, Dutt A, Dutt S (2024). Inhibition of PERK mediated UPR acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma. Neuro Oncology. PMID: 39021199.
- Lonare A, Raychaudhuri K, Shah S, Madhu G, Sachdeva A, Basu S, Thorat R, Gupta S, Dalal SN (2024). 14-3-3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer. International Journal of Cancer
- Phadte P, Bishnu A, Dey P, Manikandan M, Mehrotra M, Singh P, Chakrabarty S, Majumdar R, Rekhi B, Patra M, De A, Ray P (2024). Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells. Journal of Experimental and Clinical Cancer Research. 43(1):222. PMID: 39123206
- Rashid M, Rashid R, Gadewal N, Carethers JM, Koi M, Brim H, Ashktorab H(2024). High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer. Neoplasia. 49:100970. PMID: 38281411
- Rai A, Patwardhan R, Jayakumar S, Pachpatil P, Das D, Panigrahi G, Gota V, Patwardhan S, Sandur S (2024). Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis. Acta Pharmacologica Sinica. 45(7):1506-1519. PMID: 38480835
Select Year
order
-9